Amphenol Corp: Form 10-K for the period ended Dec 31, 2013
Filed with the SEC on Feb 21, 2014 and accepted by EDGAR at Feb 21, 2014, 14:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-10-01 to 2013-12-31 | $1.25bn | us-gaap:SalesRevenueGoodsNet |
| Revenue | 12 months2013-01-01 to 2013-12-31 | $4.61bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 12 months2013-01-01 to 2013-12-31 | $3.16bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-10-01 to 2013-12-31 | $389.3m | us-gaap:GrossProfit |
| Gross profit | 12 months2013-01-01 to 2013-12-31 | $1.45bn | us-gaap:GrossProfit |
| Research and development | 12 months2013-01-01 to 2013-12-31 | $103.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2013-01-01 to 2013-12-31 | $548.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-10-01 to 2013-12-31 | $241.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2013-01-01 to 2013-12-31 | $896.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-01-01 to 2013-12-31 | $63.6m | us-gaap:InterestExpense |
| Income tax | 12 months2013-01-01 to 2013-12-31 | $207.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-10-01 to 2013-12-31 | $167.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 12 months2013-01-01 to 2013-12-31 | $638.7m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2013-10-01 to 2013-12-31 | $1.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2013-01-01 to 2013-12-31 | $3.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-10-01 to 2013-12-31 | $1.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2013-01-01 to 2013-12-31 | $4.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2013-01-01 to 2013-12-31 | 162,274,499 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | $769.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $158.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2013-01-01 to 2013-12-31 | $96.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2013-01-01 to 2013-12-31 | $324.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2013-12-31 | $886.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $3.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $6.17bn | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $1.61bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2013-12-31 | $1.43bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-12-31 | $701.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-12-31 | $2.86bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-14-012225. Last ingested by Listed: Nov 3, 2026, 18:42 ET. Listed shows no prices and gives no investment advice.